Fig. 5From: A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patientsForest plots of the pooled risk ratios for (a) in-segment late luminal loss (in-stent LLL) and (b) in-stent late luminal loss (in-stent LLL)Back to article page